Opportunities in the Next Generation Cancer Diagnostics Market include leveraging advancements in genomic and proteomic ...
As per precedence Research, the global DNA microarray market size is projected to grow approximately USD 6.13 billion by 2034 from valued at USD 2.28 billion in 2023. It is expanding at a CAGR of 9.4% ...
Heart failure with preserved ejection fraction is a major global public health problem, while effective risk stratification tools are still lacking. We sought to construct a multi-mRNA signature to ...
Abstract: Colorectal cancer is one of the most common cancers with the second highest mortality rate in the world. The microarray can be used to collect gene expression alteration information from ...
Under non-pathological conditions, human γδ T cells represent a small fraction of CD3 + T cells in peripheral blood (1-10%). They constitute a unique subset of T lymphocytes that recognize stress ...
SomaLogic’s SOMAscan assay solves a protein measurement challenge using a DNA measurement solution, enabling the accurate measurement of an individual’s protein makeup with unequalled sensitivity and ...
Agilent Technologies and Roche have signed an exclusive agreement to provide continued service to NimbleGen microarray customers as Roche phases out its NimbleGen array production and services.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results